Evidence Linking DISC1 Gene to Mental Illness Builds

Total Page:16

File Type:pdf, Size:1020Kb

Evidence Linking DISC1 Gene to Mental Illness Builds meaning that several genes, as well as envi- ronmental factors, contribute to their devel- opment. That’s why the Scottish family proved to be such a boon. The 1990 study, which was conducted by a team including David St. Clair, Douglas Blackwood, and Walter Muir of the University of Edinburgh, U.K., suggested that the region disrupted by the translocation seen in affected members of the Scottish family held one or more genes involved in the disorders. The gene search went slowly at first, but in 2000, a team led by David Porteous and Kirsty Millar, also at Edinburgh, identified two previously unknown genes on chromo- some 1 that were interrupted by the genetic anomaly. Attention has focused on the first, DISC1, which normally produces a large pro- BEHAVIORAL GENETICS tein the structure of which suggests that it interacts with other proteins. Shortly after identification of DISC1, a Evidence Linking DISC1 Gene to follow-up study by the Edinburgh workers buttressed a causative role for the gene in the Mental Illness Builds mental disorders of the Scottish family; that linkage analysis had a high degree of sta- Animal studies add weight to the view that an important gene for brain development tistical validity—a LOD score of 7 when 3 is on December 28, 2007 plays a role in diseases such as schizophrenia and depression considered good. In this family, “we’re as close to causality as you could get,” Porteous Every clan has its misfits, but an extended think this gene is really the first big break- says. Even so, environmental influences may family in northern Scotland is extraordinary. through in schizophrenia … and other men- still be important, as a few members carry the More than half have suffered from schizo- tal diseases,” says Christopher Ross of Johns translocation but remain unaffected. phrenia or some other form of mental illness. Hopkins University School of Medicine in The Scottish family is unusual because so A group of Scottish researchers reported in Baltimore, Maryland. many members develop bipolar disorder and 1990 that the affected people all carried the After decades of following false leads, depression, as well as schizophrenia, and no www.sciencemag.org same genetic anomaly—a translocation, or researchers are cautiously optimistic that they one has detected a similar DISC1 abnormality swap, of two stretches of DNA on the long are on the right track with DISC1. But the evi- in other families. In 2003, however, Leena arms of chromosomes 1 and 11. With mod- dence isn’t airtight. Except Peltonen of the National esty, the investigators wrote that this “may be in the Scottish family, Public Health Institute in , 12 (2005) a promising area to examine” for genes that researchers haven’t consis- Helsinki, Finland, and her 7 predispose people to mental illness. tently linked any particular colleagues reported a link- The area turned out to be very promising DISC1 variant to a mental age between a particular set indeed. By the year 2000, it had led disease. “There’s no smok- of three single-nucleotide Downloaded from researchers to a gene called DISC1, which ing gun,” cautions psychia- variants (single-nucleotide may be a key player in the chain of events trist Daniel Weinberger of polymorphisms) in DISC1 leading to mental illness. The circumstantial the National Institute of and schizophrenia in a evidence for assigning a major role to Mental Health in Bethesda, group of 458 Finnish fami- CELL BIOLOGY ET AL., NATURE DISC1 (Disrupted-in-Schizophrenia 1) is Maryland. But if the connec- lies. “This is the first genetic strong. Several studies have linked the gene tion of DISC1 to mental dis- evidence that DISC1 has to schizophrenia, major depression, bipolar orders holds up, it might lead something to do with disorder, and autism; recent findings on to better therapies for treat- the more common garden DISC1’s biological function appear to sup- ing the conditions—espe- variety of schizophrenia,” port the hypothesis. cially schizophrenia, a dev- Peltonen says. Animal studies have shown that the gene astating disease that is now Other workers have is needed for normal brain development poorly controlled at best. picked up linkages between both in the embryo and later in life and that DISC1 variants and schizo- blocking its function produces subtle abnor- The hunt begins Held in place. An RNAi that phrenia in a few U.S. and malities in brain structure resembling those Gene hunters have had a blocks DISC1 synthesis prevents European families. And this migration of neurons (green) to seen in patients with schizophrenia. The pro- hard time pinning down the the upper layer of the cortex in year, the Peltonen team tein encoded by the gene also turns out to be genes involved in mental mice (right micrographs); controls linked the gene to bipolar part of a nerve cell signaling pathway disorders mainly because are on the left. disorder and to autism in involved in learning, memory, and mood. “I the diseases are complex, their Finnish population. CREDITS (TOP TO BOTTOM): SPENCER JONES/GETTY IMAGES; KAMIYA 1062 16 NOVEMBER 2007 VOL 318 SCIENCE www.sciencemag.org Published by AAAS NEWSFOCUS Research on DISC1’s normal function has In these mice, the mutant DISC1 protein DISC1 inhibits this activity until rising cAMP strengthened the case that it is involved in exerted its effects in the embryos. Another concentrations cause it to drop off the PDE4B mental disease. For starters, the gene is Johns Hopkins group led by Hongjun Song molecule. Alterations in DISC1 structure that expressed in many tissues, but particularly in has traced the gene’s effects in the brains of disrupt the normal DISC1-PDE4B interaction brain areas such as the hippocampus and cere- adult mice. In these experiments, described might therefore interfere with learning and bral cortex that are affected in schizophrenia. in the 21 September issue of Cell, the memory, among other things. “This is very That puts the gene’s protein product in the researchers showed that inhibiting DISC1 important work,” Sawa says. “Memory and right locations to influence the development expression in newly formed adult brain neu- cognition are both disturbed in schizophrenia of the mental disease. rons produces effects opposite to those seen in and bipolar disease.” In addition, as predicted from DISC1’s the other mouse models. Neurite outgrowth Additional evidence that disrupting the structure, researchers have unmasked numer- increased rather than decreased, and neurons DISC1-PDE4B interaction can affect mental ous binding partners for the protein. The cur- migrated farther than normal. “If you disrupt states comes from work on mouse models rent count stands at about 50, Porteous says, DISC1 function, everything goes faster,” developed by Steven Clapcote and John including “10 or 12 where the interaction Song says. Roder of Mount Sinai Hospital in Toronto, influences function.” Several of these partners Sawa notes that there are precedents for the Canada, and their colleagues in collaboration suggest a role for DISC1 in brain development same molecule having opposite effects with the Porteous team. (The results appeared and cognition. depending on its context. Indeed, he is now on 3 May in Neuron.) By screening a library of For example, about 5 years ago, three inde- working with Song and Pletnikov to identify mutant mice at the RIKEN research institute pendent groups, those of Porteous, Akira Sawa the molecular change that can switch DISC1’s in Japan, the researchers identified two lines of Johns Hopkins University School of activity from inhibiting to stimulating neu- of mice, each with a different DISC1 mutation Medicine, and Christopher Austin at Merck ronal migration. But whatever the outcome, that reduces DISC1 binding to PDE4B. Research Laboratory in West Point, Pennsylva- Behavioral studies further showed that nia, found that DISC1 binds to a protein called mice with one mutation display symptoms NUDEL (for NudE-like) that is needed for the construed as schizophrenia-like, including neuronal migrations that occur during brain hyperactivity and impaired learning and development. Several other partners of DISC1, memory. Those symptoms were reduced by on December 28, 2007 including FEZ1, LIS1, dynein, and tubulin, are treatment with the drug rolipram, a PDE4B also involved in nerve-cell migrations. inhibitor, and also by treatment with two That suggests that brain development drugs used to treat human schizophrenia. The might go awry if DISC1’s function is altered other mouse strain, Porteous says, had more or missing. Evidence supporting that idea depression-like symptoms. For example, includes the demonstration about 3 years ago when placed in water, the animals quickly by the Sawa team that inhibiting DISC1 syn- gave up trying to escape and simply floated. thesis in mouse embryos with small interfer- These animals responded to treatment with www.sciencemag.org ing RNAs causes abnormal migration of neu- Brain disruption. Putting a mutant human DISC1 antidepressant drugs. Developing drugs to rons to the cerebral cortex. gene in mice produces enlarged lateral ventricles regulate an enzyme such as PDE4B might More evidence comes from animal models similar to those of human schizophrenia patients. lead to better ways of treating schizophrenia developed in the past year. This fall, two Johns and other mental disorders. Hopkins groups, one led by Sawa and the researchers have long thought that schizo- The fact that DISC1 associates with so other by Mikhail Pletnikov, published reports phrenia is the result of aberrant brain develop- many different proteins might help explain on two similar mouse models produced by ment, and the results with these models but- the diversity of conditions to which it has introducing a truncated version of the DISC1 tress the case that irregularities in DISC1 been linked.
Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • DISC1 a Key Molecular Lead in Psychiatry and Neurodevelopment: No-More Disrupted-In-Schizophrenia 1
    Molecular Psychiatry (2016) 21, 1488–1489 © 2016 Macmillan Publishers Limited, part of Springer Nature. All rights reserved 1359-4184/16 www.nature.com/mp NEWS AND COMMENTARY DISC1 a key molecular lead in psychiatry and neurodevelopment: No-More Disrupted-in-Schizophrenia 1 M Niwa1, T Cash-Padgett1,4, K-I Kubo2,4, A Saito1,4, K Ishii1,4, A Sumitomo3, Y Taniguchi1, K Ishizuka1, H Jaaro-Peled1, T Tomoda3, K Nakajima2, A Sawa1 and A Kamiya1 Molecular Psychiatry (2016) 21, 1488–1489; doi:10.1038/ second, although DISC1 is a multifunctional intracellular hub mp.2016.154; published online 6 September 2016 protein, we still do not know which specific function of DISC1 underlies each endophenotype or phenotype in mental conditions. Since the middle of the past century, we have serendipitously To address the first question on genetic validity, Sullivan7 come across treatment regimens that can partially ameliorate pointed out that DISC1 is unlikely to be an important ‘genetic’ psychosis and depression. Nonetheless, the mechanisms under- factor for schizophrenia defined by the Diagnostic and Statistical lying such severe mental conditions still remain elusive. Such lack Manual of Mental Disorders (DSM). This discussion is fairly valid, of mechanistic insight into major mental illnesses has hampered and we agree with this statement and conclude as ‘No-More the establishment of precise diagnostic framework, precluding Disrupted-in-Schizophrenia 1.’ Regarding the second question, Tsuboi further discovery of fundamental treatments for these disorders. et al.8 have recently encouraged the field to reinforce the evidence Meanwhile, understanding of the brain at the molecular level that supports the role for DISC1 in early development.
    [Show full text]
  • The TRAX, DISC1, and GSK3 Complex in Mental Disorders and Therapeutic Interventions Yu-Ting Weng1,2, Ting Chien1, I-I Kuan1 and Yijuang Chern1,2*
    Weng et al. Journal of Biomedical Science (2018) 25:71 https://doi.org/10.1186/s12929-018-0473-x REVIEW Open Access The TRAX, DISC1, and GSK3 complex in mental disorders and therapeutic interventions Yu-Ting Weng1,2, Ting Chien1, I-I Kuan1 and Yijuang Chern1,2* Abstract Psychiatric disorders (such as bipolar disorder, depression, and schizophrenia) affect the lives of millions of individuals worldwide. Despite the tremendous efforts devoted to various types of psychiatric studies and rapidly accumulating genetic information, the molecular mechanisms underlying psychiatric disorder development remain elusive. Among the genes that have been implicated in schizophrenia and other mental disorders, disrupted in schizophrenia 1 (DISC1) and glycogen synthase kinase 3 (GSK3) have been intensively investigated. DISC1 binds directly to GSK3 and modulates many cellular functions by negatively inhibiting GSK3 activity. The human DISC1 gene is located on chromosome 1 and is highly associated with schizophrenia and other mental disorders. A recent study demonstrated that a neighboring gene of DISC1, translin-associated factor X (TRAX), binds to the DISC1/GSK3β complex and at least partly mediates the actions of the DISC1/GSK3β complex. Previous studies also demonstrate that TRAX and most of its interacting proteins that have been identified so far are risk genes and/or markers of mental disorders. In the present review, we will focus on the emerging roles of TRAX and its interacting proteins (including DISC1 and GSK3β) in psychiatric disorders and the potential implications for developing therapeutic interventions. Keywords: TRAX, DISC1, GSK3β, Mental disorders, DNA damage, DNA repair, Oxidative stress, A2AR, PKA Background DNA repair) by interacting with various proteins [4–12].
    [Show full text]
  • DISC1-Binding Proteins in Neural Development, Signalling and Schizophrenia
    Edinburgh Research Explorer DISC1-binding proteins in neural development, signalling and schizophrenia Citation for published version: Bradshaw, NJ & Porteous, DJ 2012, 'DISC1-binding proteins in neural development, signalling and schizophrenia', Neuropharmacology, vol. 62, no. 3, pp. 1230-41. https://doi.org/10.1016/j.neuropharm.2010.12.027 Digital Object Identifier (DOI): 10.1016/j.neuropharm.2010.12.027 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Neuropharmacology Publisher Rights Statement: Available under Open Access General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 25. Sep. 2021 Neuropharmacology 62 (2012) 1230e1241 Contents lists available at ScienceDirect Neuropharmacology journal homepage: www.elsevier.com/locate/neuropharm DISC1-binding proteins in neural development, signalling and schizophrenia Nicholas J. Bradshaw*, David J. Porteous Medical Genetics Section, Molecular Medicine Centre, Institute of Genetics & Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh, Midlothian EH4 2XU, UK article info abstract Article history: In the decade since Disrupted in Schizophrenia 1 (DISC1)wasfirst identified it has become one of the most Received 29 October 2010 convincing risk genes for major mental illness.
    [Show full text]
  • Structural and Functional Analysis of Translocation in DISC1 Gene and Impact on Schizophrenia
    CAPITAL UNIVERSITY OF SCIENCE AND TECHNOLOGY, ISLAMABAD Structural and Functional Analysis of Translocation in DISC1 gene and Impact on Schizophrenia by Jaweria Zia A thesis submitted in partial fulfillment for the degree of Master of Science in the Faculty of Health and Life Sciences Department of Bioinformatics and Biosciences 2021 i Copyright © 2021 by Jaweria Zia All rights reserved. No part of this thesis may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, by any information storage and retrieval system without the prior written permission of the author. ii I dedicate this thesis to my parents and my teachers. CERTIFICATE OF APPROVAL Structural and Functional Analysis of Translocation in DISC1 gene and Impact on Schizophrenia by Jaweria Zia (MBS191024) THESIS EXAMINING COMMITTEE S. No. Examiner Name Organization (a) External Examiner Dr. Mazhar Qayyam PMAS-UAAR, Rawalpindi (b) Internal Examiner Dr. Erum Dilshad CUST, Islamabad (c) Supervisor Dr. Syeda Marriam Bakhtiar CUST, Islamabad Dr. Syeda Marriam Bakhtiar Thesis Supervisor April, 2021 Dr. Sahar Fazal Dr. Muhammad Abdul Qadir Head Dean Dept. of Biosciences & Bioinformatics Faculty of Health & Life Sciences April, 2021 April, 2021 iv Author's Declaration I, Jaweria Zia hereby state that my MS thesis titled \Structural and Func- tional Analysis of Translocation in DISC1 gene and Impact on Schizophre- nia" is my own work and has not been submitted previously by me for taking any degree from Capital University of Science and Technology, Islamabad or anywhere else in the country/abroad. At any time if my statement is found to be incorrect even after my graduation, the University has the right to withdraw my MS Degree.
    [Show full text]
  • Abnormalities Induced by a Disc1 Mutation Modelling a Translocation Linked to Major Mental Illness Elise L
    Malavasi et al. Translational Psychiatry (2018) 8:184 DOI 10.1038/s41398-018-0228-1 Translational Psychiatry ARTICLE Open Access DISC1 regulates N-methyl-D-aspartate receptor dynamics: abnormalities induced by a Disc1 mutation modelling a translocation linked to major mental illness Elise L. V. Malavasi1,KyriakosD.Economides2, Ellen Grünewald1, Paraskevi Makedonopoulou1, Philippe Gautier3, Shaun Mackie1, Laura C. Murphy1,HannahMurdoch4,DarraghCrummie1, Fumiaki Ogawa1,DanielL.McCartney1, Shane T. O’Sullivan1,KarenBurr5, Helen S. Torrance1, Jonathan Phillips1, Marion Bonneau1,SusanM.Anderson1, Paul Perry3, Matthew Pearson3, Costas Constantinides1, Hazel Davidson-Smith1, Mostafa Kabiri6, Barbara Duff7, Mandy Johnstone 1,7,H.GregPolites8,StephenM.Lawrie 7, Douglas H. Blackwood 7, Colin A. Semple3, Kathryn L. Evans1, Michel Didier9, Siddharthan Chandran5,AndrewM.McIntosh 7, David J. Price10,MilesD.Houslay11, David J. Porteous 1 and J. Kirsty Millar1 Abstract The neuromodulatory gene DISC1 is disrupted by a t(1;11) translocation that is highly penetrant for schizophrenia and affective disorders, but how this translocation affects DISC1 function is incompletely understood. N-methyl-D-aspartate receptors (NMDAR) play a central role in synaptic plasticity and cognition, and are implicated in the pathophysiology 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; of schizophrenia through genetic and functional studies. We show that the NMDAR subunit GluN2B complexes with DISC1-associated trafficking factor TRAK1, while DISC1 interacts with the GluN1 subunit and regulates dendritic NMDAR motility in cultured mouse neurons. Moreover, in the first mutant mouse that models DISC1 disruption by the translocation, the pool of NMDAR transport vesicles and surface/synaptic NMDAR expression are increased. Since NMDAR cell surface/synaptic expression is tightly regulated to ensure correct function, these changes in the mutant mouse are likely to affect NMDAR signalling and synaptic plasticity.
    [Show full text]
  • Deletion of Densin-180 Results in Abnormal Behaviors Associated with Mental Illness and Reduces Mglur5 and DISC1 in the Postsynaptic Density Fraction
    16194 • The Journal of Neuroscience, November 9, 2011 • 31(45):16194–16207 Cellular/Molecular Deletion of Densin-180 Results in Abnormal Behaviors Associated with Mental Illness and Reduces mGluR5 and DISC1 in the Postsynaptic Density Fraction Holly J. Carlisle,1* Tinh N. Luong,1* Andrew Medina-Marino,1* Leslie Schenker,1 Eugenia Khorosheva,1 Tim Indersmitten,2 Keith M. Gunapala,1 Andrew D. Steele,1 Thomas J. O’Dell,2 Paul H. Patterson,1 and Mary B. Kennedy1 1Division of Biology, California Institute of Technology, Pasadena, California 91105, and 2 David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095 Densin is an abundant scaffold protein in the postsynaptic density (PSD) that forms a high-affinity complex with ␣CaMKII and ␣-actinin. To assess the function of densin, we created a mouse line with a null mutation in the gene encoding it (LRRC7). Homozygous knock-out mice display a wide variety of abnormal behaviors that are often considered endophenotypes of schizophrenia and autism spectrum disorders. At the cellular level, loss of densin results in reduced levels of ␣-actinin in the brain and selective reduction in the localization of mGluR5 and DISC1 in the PSD fraction, whereas the amounts of ionotropic glutamate receptors and other prominent PSD proteins are unchanged. In addition, deletion of densin results in impairment of mGluR- and NMDA receptor-dependent forms of long-term depres- sion, alters the early dynamics of regulation of CaMKII by NMDA-type glutamate receptors, and produces a change in spine morphology. These results indicate that densin influences the function of mGluRs and CaMKII at synapses and contributes to localization of mGluR5 and DISC1 in the PSD fraction.
    [Show full text]
  • DISC1 As a Genetic Risk Factor for Schizophrenia and Related Major Mental Illness: Response to Sullivan
    Molecular Psychiatry (2014) 19, 141–143 © 2014 Macmillan Publishers Limited All rights reserved 1359-4184/14 www.nature.com/mp GUEST EDITORIAL DISC1 as a genetic risk factor for schizophrenia and related major mental illness: response to Sullivan Molecular Psychiatry (2014) 19, 141–143; doi:10.1038/mp.2013.160 t(1;11); the t(1;11) shows unequivocal linkage to the high burden of major mental illness in this family, and the t(1;11) has been scored both by classical chromosome banding and by fluores- cence in situ hybridisation16. The molecular cloning of the t(1;11) breakpoint4 with sequence confirmation has more recently In a recent guest editorial,1 Patrick Sullivan questioned several allowed us to develop a PCR-based assay spanning the break- aspects of the original Scottish t(1;11) family in which the DISC1 point; we routinely apply this test to validate samples in gene was discovered.2–4 He challenged the wider significance of contemporary studies (Thomson, unpublished). Finally, regarding the original genetic finding and questioned the relevance of DISC1 the Scottish t(1;11) pedigree, a major third wave of follow-up has biology to psychiatry, casting doubt on the validity of the recently been completed with brain imaging added to the clinical ‘integrative’ approach. Sullivan prefaced his strong views on phenotype: this will be submitted shortly for publication. DISC1 by welcoming the ‘uncompromising statistical rigour and Sullivan finds the spectrum of psychiatric diagnoses seen in the replication’ that is now being applied to his area of expertise in t(1;11) family ‘worrying’, but what the t(1;11) family showed par genome-wide association studies (GWAS).
    [Show full text]
  • PAK7) Is a Risk Factor for Psychosis
    Provided by the author(s) and NUI Galway in accordance with publisher policies. Please cite the published version when available. Title An inherited duplication at the gene p21 Protein-Activated Kinase 7 (PAK7) is a risk factor for psychosis Author(s) Morris, Derek W. Publication Date 2014-01-28 Morris, D. W.,Pearson, R. D.,Cormican, P.,Kenny, E. M.,O'Dushlaine, C. T.,Perreault, L. P.,Giannoulatou, E.,Tropea, D.,Maher, B. S.,Wormley, B.,Kelleher, E.,Fahey, C.,Molinos, I.,Bellini, S.,Pirinen, M.,Strange, A.,Freeman, C.,Thiselton, D. L.,Elves, R. L.,Regan, R.,Ennis, S.,Dinan, T. G.,McDonald, C.,Murphy, K. C.,O'Callaghan, E.,Waddington, J. L.,Walsh, Publication D.,O'Donovan, M.,Grozeva, D.,Craddock, N.,Stone, Information J.,Scolnick, E.,Purcell, S.,Sklar, P.,Coe, B.,Eichler, E. E.,Ophoff, R.,Buizer, J.,Szatkiewicz, J.,Hultman, C.,Sullivan, P.,Gurling, H.,McQuillin, A.,St Clair, D.,Rees, E.,Kirov, G.,Walters, J.,Blackwood, D.,Johnstone, M.,Donohoe, G.,O'Neill, F. A.,Kendler, K. S.,Gill, M.,Riley, B. P.,Spencer, C. C.,Corvin, A. (2014) 'An inherited duplication at the gene p21 Protein-Activated Kinase 7 (PAK7) is a risk factor for psychosis'. Hum Mol Genet, 23 (1212):3316-26. Publisher Oxford University Press (OUP) Link to publisher's https://doi.org/10.1093/hmg/ddu025 version Item record http://hdl.handle.net/10379/16270 DOI http://dx.doi.org/10.1093/hmg/ddu025 Downloaded 2021-09-24T13:08:42Z Some rights reserved. For more information, please see the item record link above.
    [Show full text]
  • Comprehensive Analysis of Translin-Associated Protein X (Trnax
    International Journal of Research Studies in Biosciences (IJRSB) Volume 3, Issue 10, October 2015, PP 131- 140 ISSN 2349- 0357 (Print) & ISSN 2349- 0365 (Online) www.arcjournals.org Evolutionary Analysis of the Translin- Associated Protein X (TraX) Gene Family in Eukaryotes Jun Cao Institute of Life Science, Jiangsu University, Zhenjiang, Jiangsu, PR China [email protected] Abstract: TraX is a protein that interacts with Translin, which has been proposed to be involved in mRNA transport and translation, chromosomal translocation and DNA recombination. Although numerous studies have focused on the functional identification of TraX, limited information is known about its molecular evolution in eukaryotes. In this study, I identified 89 TraX genes in 85 selected eukaryotes species and performed a comprehensive analysis to explore the evolutionary patterns of these TraX genes. The results showed that the conserved gene structure existed in each group, indicative of their functional conservation. Some dynamic and conserved evolutionary characteristics of the TraX gene family were also investigated through synteny and karyotypes analyses. In addition, adaptive evolution analysis also indicated some positive selection sites. The results will contribute to further function research in further. Key words: TraX, evolution, synteny analysis, selection pressure 1. INTRODUCTION TraX encodes Translin- associated 33 kDa proteins partner which was first discovered in a yeast two- hybrid screen of a human cDNA library using Translin as bait (Aoki et al., 1997). These two sequences have about 28% identity with each other. TraX orthologs and Translin usually exist in the same species, indicating that they are likely to play a biological role of fundamental importance (Li et al., 2008; Jaendling and McFarlane, 2010).
    [Show full text]
  • DISC1 Splice Variants Are Upregulated in Schizophrenia and Associated with Risk Polymorphisms
    DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms Kenji Nakata1, Barbara K. Lipska1,2, Thomas M. Hyde, Tianzhang Ye, Erin N. Newburn, Yukitaka Morita, Radhakrishna Vakkalanka, Maxim Barenboim, Yoshitatsu Sei, Daniel R. Weinberger, and Joel E. Kleinman Clinical Brain Disorders Branch, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892-1385 Edited by Floyd E. Bloom, The Scripps Research Institute, La Jolla, CA, and approved July 22, 2009 (received for review April 7, 2009) Disrupted-In-Schizophrenia-1 (DISC1) is a promising susceptibility therefore is plausible that changes in gene processing occur in gene for major mental illness, but the mechanism of the clinical patients who have major mental illness (28, 31–36). association is unknown. We searched for DISC1 transcripts in adult In this study, we characterize DISC1 mRNA processing in adult and fetal human brain and tested whether their expression is and fetal human brain and in lymphoblasts. We show that tran- altered in patients with schizophrenia and is associated with scripts encoding truncated DISC1 proteins in transfected HEK293 genetic variation in DISC1. Many alternatively spliced transcripts cells are expressed at significantly higher levels in the cerebral were identified, including groups lacking exon 3 (⌬3), exons 7 and cortex during normal human fetal development than later in life, 8(⌬7⌬8), an exon 3 insertion variant (extra short variant-1, Esv1), are enriched in the hippocampus of patients with schizophrenia, and intergenic splicing between TSNAX and DISC1. Isoforms and are related to the previously identified risk-associated poly- ⌬7⌬8, Esv1, and ⌬3, which encode truncated DISC1 proteins, were morphisms (20–21, 37–40).
    [Show full text]
  • Structural Interaction Between DISC1 and ATF4 Underlying Transcriptional and Synaptic Dysregulation in an Ipsc Model of Mental Disorders
    Molecular Psychiatry https://doi.org/10.1038/s41380-019-0485-2 ARTICLE Structural interaction between DISC1 and ATF4 underlying transcriptional and synaptic dysregulation in an iPSC model of mental disorders 1,2 3,4 5,6 2 3 2,7 Xinyuan Wang ● Fei Ye ● Zhexing Wen ● Ziyuan Guo ● Chuan Yu ● Wei-Kai Huang ● 8 2 9 1 2 Francisca Rojas Ringeling ● Yijing Su ● Wei Zheng ● Guomin Zhou ● Kimberly M. Christian ● 2,10,11,12 3,4 2,10,11,13 Hongjun Song ● Mingjie Zhang ● Guo-li Ming Received: 13 October 2018 / Revised: 1 April 2019 / Accepted: 17 May 2019 © The Author(s), under exclusive licence to Springer Nature Limited 2019 Abstract Psychiatric disorders are a collection of heterogeneous mental disorders arising from a contribution of genetic and environmental insults, many of which molecularly converge on transcriptional dysregulation, resulting in altered synaptic functions. The underlying mechanisms linking the genetic lesion and functional phenotypes remain largely unknown. Patient iPSC-derived neurons with a rare frameshift DISC1 (Disrupted-in-schizophrenia 1) mutation have 1234567890();,: 1234567890();,: previously been shown to exhibit aberrant gene expression and deficits in synaptic functions. How DISC1 regulates gene expression is largely unknown. Here we show that Activating Transcription Factor 4 (ATF4), a DISC1 binding partner, is more abundant in the nucleus of DISC1 mutant human neurons and exhibits enhanced binding to a collection of dysregulated genes. Functionally, overexpressing ATF4 in control neurons recapitulates deficits seen in DISC1 mutant neurons, whereas transcriptional and synaptic deficits are rescued in DISC1 mutant neurons with CRISPR-mediated heterozygous ATF4 knockout. By solving the high-resolution atomic structure of the DISC1–ATF4 complex, we show that mechanistically, the mutation of DISC1 disrupts normal DISC1–ATF4 interaction, and results in excessive ATF4 binding to DNA targets and deregulated gene expression.
    [Show full text]